Hospira to provide Theradiag’s LISA TRACKER infliximab monitoring kits jointly with biosimilar Inflectra® in Europe, Canada and Australia Croissy-Beaubourg and Montpellier, May 20, 2015 – Theradiag (ISIN: FR0004197747, Ticker: ALTER), a company specializing in theranostics…
Exclusive partnership agreement with Somagen Diagnostics Inc.First North American market penetration for LISA TRACKERPositive recommendation by Canadian health authorities on biotherapy monitoring Croissy-Beaubourg and Montpellier, May 11, 2015 – Theradiag (ISIN: FR0004197747, Ticker: ALTER), a company specializing…
A study conducted at the Saint-Etienne University Hospital sustains the relevance of infliximab monitoring with LISA TRACKER kits and dosing of C-Reactive Protein (CRP) to predict loss of response in IBD patientsMonitoring of biotherapies with…